{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-043924","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.470452+00:00","generated_at":"2026-05-30T03:40:59.494511+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Celularity raises FY 2024 net sales guidance to $54-60M; October sales hit record $8.3-8.9M","bullets":["Raises full-year 2024 expected net sales guidance to $54M-$60M from $50M-$56M, citing strong advanced biomaterial sales.","Expected net sales through October 31, 2024: $44.4M ($40.2M advanced biomaterials, $4.2M biobanking); includes ~$9M from new Rebound product.","October 2024 expected net sales of $8.3M-$8.9M marks highest-ever single-month figure.","Filed Q2 2024 Form 10-Q on Nov 6, resolving Nasdaq non-compliance notice from Oct 16, 2024.","Advanced biomaterial product sales for first half 2024 exceeded $24M, surpassing full-year 2023 total."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-043924","json":"https://secwatch.observer/filing/0001493152-24-043924.json","markdown":"https://secwatch.observer/filing/0001493152-24-043924.md","text":"https://secwatch.observer/filing/0001493152-24-043924.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224043924/0001493152-24-043924-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224043924/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:40:59.494511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}